Role of CYP2E1 gene polymorphisms association with hepatitis risk in Northeast India

World Journal of Gastroenterology

Volumn 16, Issue 38, 2010, Pages 4800-4808

  Deka, Manab ^a   Bose, Moumita ^a   Baruah, Bharati ^a   Bose, Purabi Deka ^b   Medhi, Subhash ^a   Bose, Sujoy ^a   Saikia, Anjan ^c   Kar, Premashish ^b  

^a GAUHATI UNIVERSITY   (India)

^b MAULANA AZAD MEDICAL COLLEGE   (India)

^c Medical and Gastroenterology Unit   (India)

Author keywords

Cytochrome P450 2E1; Gene polymorphism; Nitrites; Nitrosamines; Viral hepatitis

Indexed keywords

CYTOCHROME P450 2E1; NITRITE; NITROSAMINE;

ADULT; ALCOHOLISM; ALLELE; ARTICLE; BETEL NUT; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEPATITIS; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS E; HUMAN; INDIA; JAUNDICE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEQUENCE ANALYSIS;

EID: 78049500470     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i38.4800     Document Type: Article

References (44)

1. Shields PG. Inherited factors and environmental exposures in cancer risk. J Occup Med 1993; 35: 34-41
2. Shields PG, Harris CC. Molecular epidemiology and the genetics of environmental cancer. JAMA 1991; 266: 681-687
3. Bortolotti F. Chronic hepatitis B acquired in childhood: un- answered questions and evolving issues. J Hepatol 1994; 21: 904-909
4. Bosch FX, Muñoz N. Prospects for epidemiological studies on hepatocellular cancer as a model for assessing viral and chemical interactions. IARC Sci Publ 1988; 89: 427-438
5. Shank RC, Bhamarapravati N, Gordon JE, Wogan GN. Dietary aflatoxins and human liver cancer. IV. Incidence of primary liver cancer in two municipal populations of Thailand. Food Cosmet Toxicol 1972; 10: 171-179
6. Austin H, Delzell E, Grufferman S, Levine R, Morrison AS, Stolley PD, Cole P. A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res 1986; 46: 962-966
7. Thamavit W, Bhamarapravati N, Sahaphong S, Vajrasthira S, Angsubhakorn S. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res 1978; 38: 4634-4639
8. Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol 2002; 17: 165-170
9. Tanaka K, Ikematsu H, Hirohata T, Kashiwagi S. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection. J Natl Cancer Inst 1996; 88: 742-746
10. Guslitser LN. Epidemiology of tumors: the main results of the studies carried in R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine. Exp Oncol 2001; 23: 229-235
11. Spiegelhalder B, Eisenbrand G, Preussmann R. Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet Toxicol 1976; 14: 545-548
12. Ramaiah SK, Apte U, Mehendale HM. Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats. Drug Metab Dispos 2001; 29: 1088-1095
13. Guengerich FP, Kim DH, Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 1991; 4: 168-179
14. Nakajima T, Aoyama T. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals. Ind Health 2000; 38: 143-152
15. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000; 9: 3-28
16. Camus AM, Geneste O, Honkakoski P, Bereziat JC, Henderson CJ, Wolf CR, Bartsch H, Lang MA. High variability of nitrosamine metabolism among individuals: role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans. Mol Carcinog 1993; 7: 268-275
17. Kang JS, Wanibuchi H, Morimura K, Gonzalez FJ, Fukushima S. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo. Cancer Res 2007; 67: 11141-11146
18. Nomura F, Itoga S, Uchimoto T, Tomonaga T, Nezu M, Shimada H, Ochiai T. Transcriptional activity of the tandem repeat polymorphism in the 5'-flanking region of the human CYP2E1 gene. Alcohol Clin Exp Res 2003; 27: 42S-46S
19. Uematsu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Ohmachi T, Wakui A, Kanamaru R, Watanabe M. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res 1991; 82: 254-256
20. Kirschberg O, Schuttler C, Repp R, Schaefer S. A multiplex-PCR to identify hepatitis B virus--enotypes A-F. J Clin Virol 2004; 29: 39-43
21. Das U, Kar P, Gopalkrishna V, Sharma JK, Madan K, Das BC. Comparative evaluation of hepatitis C virus infection in serum and liver tissue of patients with chronic liver disease by reverse transcription-polymerase chain reaction. Clin Microbiol Infect 1999; 5: 256-261
22. Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, Sardana S, Kar P. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol 2007; 22: 676-682
23. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991; 110: 559-565
24. Lu XM, Zhang YM, Lin RY, Arzi G, Wang X, Zhang YL, Zhang Y, Wang Y, Wen H. Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China. World J Gastroenterol 2005; 11: 3651-3654
25. Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H, Weston A, Harris CC. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res 1992; 52: 6712-6715
26. Kato S, Shields PG, Caporaso NE, Sugimura H, Trivers GE, Tucker MA, Trump BF, Weston A, Harris CC. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol Biomarkers Prev 1994; 3: 515-518
27. Mitacek EJ, Brunnemann KD, Suttajit M, Martin N, Limsila T, Ohshima H, Caplan LS. Exposure to N-nitroso compounds in a population of high liver cancer regions in Thailand: volatile nitrosamine (VNA) levels in Thai food. Food Chem Toxicol 1999; 37: 297-305
28. Ceyhan M, Yildirim I, Kurt N, Uysal G, Dikici B, Ecevit C, Aydogan A, Koc A, Yasa O, Koseoglu M, Onal K, Hacimustafaoglu M, Celebi S. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. J Viral Hepat 2008; 15 Suppl 2: 69-72
29. Mathur P, Arora NK. Epidemiological transition of hepatitis A in India: issues for vaccination in developing countries. Indian J Med Res 2008; 128: 699-704
30. Nayak NC, Panda SK, Zuckerman AJ, Bhan MK, Guha DK. Dynamics and impact of perinatal transmission of hepatitis B virus in North India. J Med Virol 1987; 21: 137-145
31. Roychoudhury A, Bhattacharyya DK. Incidence of hepatitis B carriers in Calcutta, West Bengal. J Assoc Physicians India 1989; 37: 160-161
32. Tandon BN, Gandhi BM, Joshi YK. Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in north India. Bull World Health Organ 1984; 62: 67-73
33. Verma J, Joshi PL, Raj B, Bhattacharaya M, Sebastian M, Kumari S. An epidemiological study of hepatitis B virus amongst blood donors. J Commun Dis 1989; 21: 52-58
34. Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, Das BC. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol 2001; 16: 666-673
35. Borkakoty BJ, Mahanta J, Biswas D. Circulating genotypes of hepatitis B virus in Arunachal Pradesh. Indian J Med Res 2008; 127: 65-70
36. Acharya SK, Madan K, Dattagupta S, Panda SK. Viral hepatitis in India. Natl Med J India 2006; 19: 203-217
37. Ladero JM, Agúndez JA, Rodríguez-Lescure A, Diaz-Rubio M, Benítez J. RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma. Gut 1996; 39: 330-333
38. London SJ, Daly AK, Cooper J, Carpenter CL, Navidi WC, Ding L, Idle JR. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics 1996; 6: 151-158
39. Wu X, Shi H, Jiang H, Kemp B, Hong WK, Delclos GL, Spitz MR. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 1997; 18: 967-973
40. Hildesheim A, Chen CJ, Caporaso NE, Cheng YJ, Hoover RN, Hsu MM, Levine PH, Chen IH, Chen JY, Yang CS. Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev 1995; 4: 607-610
41. Soya SS, Padmaja N, Adithan C. Genetic polymorphisms of CYP2E1 and GSTP1 in a South Indian population--comparison with North Indians, Caucasians and Chinese. Asian Pac J Cancer Prev 2005; 6: 315-319
42. Dupont I, Lucas D, Clot P, Mânez C, Albano E. Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics. J Hepatol 1998; 28: 564-571
43. Tsai JF, Jeng JE, Chuang LY, Ho MS, Ko YC, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY. Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine (Baltimore) 2004; 83: 176-187
44. Srivatanakul P, Parkin DM, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, L'Abbe KA, Wild CP. Liver cancer in Thailand. II. A case-control study of hepatocellular carcinoma. Int J Cancer 1991; 48: 329-332